PuraCap Introduces Two New Acne Products to its Popular Eptex, Physiologic Skin Care Line

Company officials say that the introduction of these new acne products for Eptex is a major boost to PuraCap’s growing portfolio of dermatology products.

Online PR News – 08-February-2017 – According to Dahai Guo, CEO of PuraCap Pharmaceutical LLC (www.puracap.com), an emerging, fully-integrated pharmaceutical company that brings affordable, world-class quality products to the market, the company recently added two new acne products to its Eptex line of intelligent, physiologic skin repair formulations. The products include Eptex Controlled Release Acne Wash and Eptex Controlled Release Acne Relief Lotion.

These new Eptex products offer Acne treatment utilizing cutting-edge delivery systems and proven ingredients to effectively treat acne in patients suffering from sensitive skin, explains Guo. When added to our existing line, which currently includes the popular EpiCeram Controlled Release Skin Barrier Emulsion, a leading prescription product indicated for atopic dermatitis and related skin conditions, PuraCaps portfolio of dermatology products continues its steady growth.

According to Elise Geiger, Vice President and General Manager of PuraCap’s Branded Rx division, both of the new Eptex acne treatment products utilize a controlled release Intelli-Target technology that delivers treatment where it’s needed and most effective, minimizing the side effects typically associated with acne treatments.

Each product also contains MultiSal Neolipids, which are foundational lipids for skin barrier repair, and are ideal for both teens and adults, Geiger says. Eptex is available exclusively through participating healthcare professionals and directly from www.eptexskincare.com.

Gao said, We are proud of PuraCaps strong, growing portfolio of dermatology products and we are committed to continuing to offer innovative solutions to meet the needs of people with dermatological conditions with our Eptex skin care product line.

According to Geiger, these new acne alternatives enable patients to reap the benefits of benchmark treatments while minimizing any potential side effects typically associated with acne treatments.

“We look forward to partnering with physicians to provide these intelligent acne products to patients,” she said.

PuraCap Pharmaceutical LLC is an emerging, fully-integrated pharmaceutical company with expertise in product development and manufacturing, bringing affordable, world-class quality products to their customers. The PuraCap corporate structure supports a two-pronged approach for global growth with dedicated companies in the areas of prescription and OTC private label brands (PuraCap Pharmaceutical) as well as prescription generics (Puracap Laboratories). PuraCap Pharmaceutical continues to innovate using soft gel expertise and developing other oral solid dosage options. For more information, visit the companys website at www.puracap.com.